Researchers have been excited about this new drug, a innovative dual treatment showing significant results in initial trials for size management. It acts by impacting both pathways : GLP-1 and GIP, which , when activated , support influence hunger and enhance metabolism . Preliminary observations indicate substantial body management and possible be